Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer - Hohaus, Stefan; Funk, Liane; Martin, Simona; Schlenk, Richard Friedrich; Abdallah Khalafallah, Alhossain; Hahn, Uwe; Egerer, Gerlinde; Goldschmidt, Hartmut; Schneeweiss, Andreas; Fersis, Nikolaos Erich; Kaul, Sepp; Wallwiener, Diethelm; et al. (British journal of cancer, 1999)
Gesehen am 01.03.2022